Adaptive Biotechnologies Corporation
US ˙ NasdaqGS ˙ US00650F1093

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Eric Dobmeier. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Eric Dobmeier telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:JANX / Janux Therapeutics, Inc. Director 9,981
US:ATRA / Atara Biotherapeutics, Inc. Director 563,325
US:KDNY / Chinook Therapeutics Inc President, CEO, Director 0
US:ADPT / Adaptive Biotechnologies Corporation Director 3,759
US:VSAR / Versartis, Inc.. Director 18,160
US:SGEN / Seagen Inc Chief Operating Officer 24,700
US:STML / Stemline Therapeutics, Inc. Director 24,000
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Eric Dobmeier. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam ADPT / Adaptive Biotechnologies Corporation - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ADPT / Adaptive Biotechnologies Corporation. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

ADPT / Adaptive Biotechnologies Corporation Insider Trades
Penjualan Orang Dalam ADPT / Adaptive Biotechnologies Corporation - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ADPT / Adaptive Biotechnologies Corporation. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2020-06-03 ADPT DOBMEIER ERIC 5,000 39.7900 5,000 39.7900 198,950 341 32.22 -37,850 -19.02

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

ADPT / Adaptive Biotechnologies Corporation Insider Trades
Pembelian Orang Dalam ATRA / Atara Biotherapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ADPT / Adaptive Biotechnologies Corporation. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2023-11-10 ATRA DOBMEIER ERIC 446,825 0.2268 17,873 5.6700 101,340 84 30.5 443,788 437.92
2019-06-27 ATRA DOBMEIER ERIC 2,000 19.5000 80 487.5000 39,000
2016-03-17 ATRA DOBMEIER ERIC 3,000 13.8550 120 346.3750 41,565
2015-12-16 ATRA DOBMEIER ERIC 2,500 22.0000 100 550.0000 55,000

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

ATRA / Atara Biotherapeutics, Inc. Insider Trades
Penjualan Orang Dalam ATRA / Atara Biotherapeutics, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ADPT / Adaptive Biotechnologies Corporation. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

ATRA / Atara Biotherapeutics, Inc. Insider Trades
Pembelian Orang Dalam JANX / Janux Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ADPT / Adaptive Biotechnologies Corporation. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

JANX / Janux Therapeutics, Inc. Insider Trades
Penjualan Orang Dalam JANX / Janux Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ADPT / Adaptive Biotechnologies Corporation. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

JANX / Janux Therapeutics, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Eric Dobmeier sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-06-13 2025-06-11 4 JANX Janux Therapeutics, Inc.
Common Stock
A - Award 3,750 9,981 60.18
2024-07-24 2024-07-19 4/A JANX Janux Therapeutics, Inc.
Common Stock
A - Award 1,231 6,231 24.62
2024-07-22 2024-07-19 4 JANX Janux Therapeutics, Inc.
Common Stock
A - Award 2,500 7,500 50.00
2024-07-22 2024-07-19 4 JANX Janux Therapeutics, Inc.
Common Stock
A - Award 5,000 5,000
2023-11-14 2023-11-10 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
P - Purchase 446,825 563,325 383.54 0.23 101,340 127,762
2023-08-11 2023-08-11 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
D - Sale to Issuer -301,138 0 -100.00
2023-06-02 2023-05-31 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 57,000 116,500 95.80
2023-04-26 2023-04-24 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
S - Sale X 1,200 301,138 0.40 22.26 26,711 6,703,091
2023-04-26 2023-04-24 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
S - Sale X -23,800 302,338 -7.30 21.58 -513,528 6,523,487
2023-04-26 2023-04-24 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 25,000 326,138 8.30 0.42 10,500 136,978
2023-02-15 2023-02-10 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
S - Sale -8,097 301,138 -2.62 23.75 -192,292 7,151,576
2023-02-15 2023-02-10 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 20,248 309,235 7.01
2023-02-01 2023-01-31 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
S - Sale -7,688 288,987 -2.59 24.68 -189,757 7,132,835
2023-02-01 2023-01-31 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 24,999 296,675 9.20
2023-02-01 2023-01-30 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
S - Sale X -25,000 271,676 -8.43 24.54 -613,612 6,668,152
2023-02-01 2023-01-30 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 25,000 296,676 9.20 0.42 10,500 124,604
2022-12-15 2022-12-14 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 30,000 271,676 12.41 0.35 10,500 95,087
2022-12-02 2022-12-01 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
S - Sale X -30,000 241,676 -11.04 22.31 -669,351 5,392,202
2022-12-02 2022-12-01 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 60,000 271,676 28.35 0.42 25,200 114,104
2022-12-02 2022-12-01 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
G - Gift -25,000 211,676 -10.56
2022-10-11 2022-10-06 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 30,796 236,676 14.96
2022-06-27 2022-06-23 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 20,500 59,500 52.56
2022-05-27 2022-05-25 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
P - Purchase 5,000 205,880 2.49 13.03 65,148 2,682,513
2022-02-14 2022-02-10 4 KDNY CHINOOK THERAPEUTICS, INC.
Restricted Stock Units (RSU)
M - Exercise -20,247 40,496 -33.33
2022-02-14 2022-02-10 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 20,247 200,880 11.21
2022-02-02 2022-01-31 4 KDNY CHINOOK THERAPEUTICS, INC.
Restricted Stock (RSU)(Common Stock)
A - Award 75,000 75,000
2022-02-02 2022-01-31 4 KDNY CHINOOK THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 300,000 300,000
2021-12-27 2021-12-23 4 KDNY CHINOOK THERAPEUTICS, INC.
Stock Option (Right to Buy)
M - Exercise -40,000 383,358 -9.45
2021-12-27 2021-12-23 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 40,000 180,633 28.44 0.35 14,000 63,222
2021-10-08 2021-10-06 4 KDNY CHINOOK THERAPEUTICS, INC.
Restricted Stock Units (RSU)
M - Exercise -30,796 61,593 -33.33
2021-10-08 2021-10-06 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 30,796 140,633 28.04
2021-09-22 2021-09-20 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
P - Purchase 2,000 109,837 1.85 12.00 24,000 1,318,044
2021-08-19 2021-08-19 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
P - Purchase 3,000 107,837 2.86 12.00 36,000 1,294,044
2021-08-19 2021-08-18 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
P - Purchase 7,000 104,837 7.15 11.74 82,163 1,230,535
2021-06-15 2021-06-14 4 KDNY CHINOOK THERAPEUTICS, INC.
Stock Option (Right to Buy)
M - Exercise -20,000 423,358 -4.51
2021-06-15 2021-06-14 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 20,000 97,837 25.69 0.35 7,000 34,243
2021-06-09 2021-06-08 4 ATRA Atara Biotherapeutics, Inc.
Non-Qualified Stock Option (Right to Buy)
A - Award 17,500 17,500
2021-06-09 2021-06-08 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 11,000 39,000 39.29
2021-05-18 2021-05-14 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
P - Purchase 1,000 77,837 1.30 14.44 14,440 1,123,966
2021-02-17 2021-02-14 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
A - Award 3,759 3,759
2021-02-17 2021-02-14 4 ADPT Adaptive Biotechnologies Corp
Common Stock
A - Award 1,504 1,504
2021-02-12 2021-02-10 4 KDNY CHINOOK THERAPEUTICS, INC.
Restricted Stock (RSU)(Common Stock)
A - Award 60,743 60,743
2021-02-12 2021-02-10 4 KDNY CHINOOK THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 178,600 178,600
2021-01-06 2021-01-04 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
M - Exercise X -10,000 35,000 -22.22
2021-01-06 2021-01-04 4 ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale X -400 0 -100.00 59.46 -23,784
2021-01-06 2021-01-04 4 ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale X -592 400 -59.68 58.67 -34,733 23,468
2021-01-06 2021-01-04 4 ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale X -5,725 992 -85.23 57.76 -330,676 57,298
2021-01-06 2021-01-04 4 ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale X -3,283 6,717 -32.83 56.10 -184,176 376,824
2021-01-06 2021-01-04 4 ADPT Adaptive Biotechnologies Corp
Common Stock
M - Exercise X 10,000 10,000 6.32 63,200 63,200
2020-12-22 2020-12-21 4 KDNY CHINOOK THERAPEUTICS, INC.
Stock Option (right to buy)
M - Exercise -20,000 443,358 -4.32
2020-12-22 2020-12-21 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 20,000 76,837 35.19 0.35 7,000 26,893
2020-12-10 2020-12-09 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
P - Purchase 2,000 56,837 3.65 13.08 26,150 743,144
2020-12-10 2020-12-08 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
P - Purchase 2,000 54,837 3.79 13.24 26,483 726,135
2020-11-23 2020-11-23 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
P - Purchase 929 52,837 1.79 13.67 12,699 722,245
2020-11-23 2020-11-20 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
P - Purchase 571 51,908 1.11 13.69 7,817 710,621
2020-11-23 2020-11-19 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
P - Purchase 500 51,337 0.98 13.50 6,750 693,050
2020-11-13 2020-11-11 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
P - Purchase 2,500 50,837 5.17 13.75 34,375 699,009
2020-11-13 2020-11-10 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
P - Purchase 2,000 48,337 4.32 13.86 27,720 669,951
2020-10-07 2020-10-06 4 KDNY ADURO BIOTECH, INC.
Restricted Stock (RSU) (Common Stock)
A - Award 92,389 92,389
2020-10-07 2020-10-06 4 KDNY ADURO BIOTECH, INC.
Stock Option (right to buy)
A - Award 271,647 271,647
2020-10-07 2020-10-05 4 KDNY ADURO BIOTECH, INC.
Stock Option (right to buy)
A - Award 423,555 423,555
2020-10-07 2020-10-05 4 KDNY ADURO BIOTECH, INC.
Stock Option (right to buy)
A - Award 463,358 463,358
2020-10-07 2020-10-05 4 KDNY ADURO BIOTECH, INC.
Common Stock
A - Award 46,337 46,337
2020-10-02 2020-10-01 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
M - Exercise X -10,000 45,000 -18.18
2020-10-02 2020-10-01 4 ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale X -776 0 -100.00 49.21 -38,187
2020-10-02 2020-10-01 4 ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale X -9,224 776 -92.24 48.47 -447,087 37,613
2020-10-02 2020-10-01 4 ADPT Adaptive Biotechnologies Corp
Common Stock
M - Exercise X 10,000 10,000 6.32 63,200 63,200
2020-07-08 2020-07-06 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
M - Exercise X -10,000 55,000 -15.38
2020-07-08 2020-07-06 4 ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale X -400 0 -100.00 47.98 -19,192
2020-07-08 2020-07-06 4 ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale X -9,600 400 -96.00 47.34 -454,464 18,936
2020-07-08 2020-07-06 4 ADPT Adaptive Biotechnologies Corp
Common Stock
M - Exercise X 10,000 10,000 6.32 63,200 63,200
2020-06-17 2020-06-16 4 ATRA Atara Biotherapeutics, Inc.
Non-Qualified Stock Option (Right to Buy)
A - Award 24,500 24,500
2020-06-17 2020-06-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 8,000 28,000 40.00
2020-06-05 2020-06-03 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
M - Exercise -5,000 65,000 -7.14
2020-06-05 2020-06-03 4 ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale -5,000 0 -100.00 39.79 -198,950
2020-06-05 2020-06-03 4 ADPT Adaptive Biotechnologies Corp
Common Stock
M - Exercise 5,000 5,000 6.32 31,600 31,600
2020-05-21 2020-05-19 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
M - Exercise X -5,000 70,000 -6.67
2020-05-21 2020-05-19 4 ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale X -5,000 0 -100.00 40.00 -200,000
2020-05-21 2020-05-19 4 ADPT Adaptive Biotechnologies Corp
Common Stock
M - Exercise X 5,000 5,000 6.32 31,600 31,600
2020-05-08 2020-05-07 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
M - Exercise X -5,000 75,000 -6.25
2020-05-08 2020-05-07 4 ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale X -5,000 0 -100.00 35.00 -175,000
2020-05-08 2020-05-07 4 ADPT Adaptive Biotechnologies Corp
Common Stock
M - Exercise X 5,000 5,000 6.32 31,600 31,600
2020-02-18 2020-02-13 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
A - Award 8,888 8,888
2020-01-07 2019-12-26 4/A ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
M - Exercise X -15,000 85,000 -15.00
2020-01-07 2019-12-26 4/A ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale X -2 0 -100.00 29.91 -60
2020-01-07 2019-12-26 4/A ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale X -14,998 2 -99.99 29.29 -439,291 59
2020-01-07 2019-12-26 4/A ADPT Adaptive Biotechnologies Corp
Common Stock
M - Exercise X 15,000 15,000 6.32 94,800 94,800
2020-01-07 2019-12-31 4/A ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
M - Exercise X -5,000 80,000 -5.88
2020-01-07 2019-12-31 4/A ADPT Adaptive Biotechnologies Corp
Common Stock
S - Sale X -5,000 0 -100.00 30.00 -150,000
2020-01-07 2019-12-31 4/A ADPT Adaptive Biotechnologies Corp
Common Stock
M - Exercise X 5,000 5,000 6.32 31,600 31,600
2020-01-03 2019-12-31 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
M - Exercise X -5,000 80,000 -5.88
2020-01-03 2019-12-31 4 ADPT Adaptive Biotechnologies Corp
Common Stock
D - Sale to Issuer X -5,000 0 -100.00 30.00 -150,000
2020-01-03 2019-12-31 4 ADPT Adaptive Biotechnologies Corp
Common Stock
M - Exercise X 5,000 5,000 6.32 31,600 31,600
2019-12-30 2019-12-26 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
M - Exercise X -15,000 85,000 -15.00
2019-12-30 2019-12-26 4 ADPT Adaptive Biotechnologies Corp
Common Stock
D - Sale to Issuer X -2 0 -100.00 29.91 -60
2019-12-30 2019-12-26 4 ADPT Adaptive Biotechnologies Corp
Common Stock
D - Sale to Issuer X -14,998 2 -99.99 29.29 -439,291 59
2019-12-30 2019-12-26 4 ADPT Adaptive Biotechnologies Corp
Common Stock
M - Exercise X 15,000 15,000 6.32 94,800 94,800
2019-07-01 2019-06-27 4 ATRA Atara Biotherapeutics, Inc.
Non-Qualified Stock Option (Right to Buy)
A - Award 13,000 13,000
2019-07-01 2019-06-27 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 4,000 20,000 25.00
2019-07-01 2019-06-27 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
P - Purchase 2,000 16,000 14.29 19.50 39,000 312,000
2018-06-18 2018-06-14 4 ATRA Atara Biotherapeutics, Inc.
Non-Qualified Stock Option (Right to Buy)
A - Award 5,000 5,000
2018-06-18 2018-06-14 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 1,500 14,000 12.00
2017-12-22 2017-12-20 4 VSAR Versartis, Inc.
Common Stock
A - Award 11,200 18,160 160.92
2017-12-06 2017-12-04 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -3,729 24,700 -13.12
2017-12-06 2017-12-04 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -2,436 0 -100.00
2017-12-06 2017-12-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2,436 119,860 2.07 41.04 99,973 4,919,054
2017-12-06 2017-12-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -3,729 117,424 -3.08 58.75 -219,092 6,899,071
2017-12-06 2017-12-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 3,729 121,153 3.18 26.10 97,327 3,162,093
2017-11-17 2017-11-17 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -10,000 28,429 -26.02
2017-11-17 2017-11-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -10,000 117,424 -7.85 59.12 -591,250 6,942,694
2017-11-17 2017-11-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 10,000 127,424 8.52 26.10 261,000 3,325,766
2017-11-17 2017-11-16 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -6,911 38,429 -15.24
2017-11-17 2017-11-16 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -8,489 0 -100.00
2017-11-17 2017-11-16 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -8,489 117,424 -6.74 57.95 -491,938 6,804,721
2017-11-17 2017-11-16 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 8,489 125,913 7.23 15.46 131,240 1,946,615
2017-11-17 2017-11-16 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -6,911 117,424 -5.56 57.98 -400,700 6,808,244
2017-11-17 2017-11-16 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 6,911 124,335 5.89 26.10 180,377 3,245,144
2017-11-17 2017-11-15 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -9,600 8,489 -53.07
2017-11-17 2017-11-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -9,600 117,424 -7.56 57.80 -554,837 6,786,579
2017-11-17 2017-11-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 9,600 127,024 8.18 15.46 148,416 1,963,791
2017-09-05 2017-08-31 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -25,000 18,089 -58.02
2017-09-05 2017-08-31 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -25,000 117,424 -17.55 52.24 -1,305,892 6,133,725
2017-09-05 2017-08-31 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 25,000 142,424 21.29 15.46 386,500 2,201,875
2017-08-30 2017-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -5,343 117,424 -4.35 47.89 -255,900 5,623,964
2017-08-18 2017-08-17 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 85,344 85,344
2017-08-18 2017-08-17 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2,156 2,156
2017-08-18 2017-08-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 35,000 122,767 39.88
2017-06-20 2017-06-19 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy)
A - Award 24,000 24,000
2017-06-20 2017-06-19 4 STML STEMLINE THERAPEUTICS INC
Common Stock
A - Award 10,000 27,963 55.67
2017-06-12 2017-06-08 4 ATRA Atara Biotherapeutics, Inc.
Non-Qualified Stock Option (Right to Buy)
A - Award 21,500 21,500
2017-06-12 2017-06-08 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 5,000 12,500 66.67
2017-06-06 2017-05-25 4 VSAR Versartis, Inc.
Stock Option (Right to Buy)
A - Award 6,850 6,850
2017-06-06 2017-05-25 4 VSAR Versartis, Inc.
Stock Option (Right to Buy)
A - Award 6,850 6,850
2017-06-06 2017-05-25 4 VSAR Versartis, Inc.
Common Stock
A - Award 3,480 6,960 100.00
2017-06-06 2017-05-25 4 VSAR Versartis, Inc.
Common Stock
A - Award 3,480 6,960 100.00
2017-06-06 3 VSAR Versartis, Inc.
Common Stock
0
2017-01-05 2017-01-03 4 ATRA Atara Biotherapeutics, Inc.
Non-Qualified Stock Option (Right to Buy)
A - Award 5,500 5,500
2017-01-05 2017-01-03 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 2,000 7,500 36.36
2016-12-12 2016-12-08 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -9,700 0 -100.00
2016-12-12 2016-12-08 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -2,800 9,700 -22.40
2016-12-12 2016-12-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -9,700 87,767 -9.95 65.90 -639,234 5,783,880
2016-12-12 2016-12-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 9,700 97,467 11.05 20.52 199,044 2,000,023
2016-12-12 2016-12-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -2,800 87,767 -3.09 66.00 -184,808 5,792,885
2016-12-12 2016-12-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2,800 90,567 3.19 20.52 57,456 1,858,435
2016-09-15 2016-09-14 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -300 0 -100.00
2016-09-15 2016-09-14 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -22,618 300 -98.69
2016-09-15 2016-09-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -300 87,767 -0.34 54.41 -16,324 4,775,692
2016-09-15 2016-09-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 300 88,067 0.34 12.00 3,600 1,056,804
2016-09-15 2016-09-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -22,618 87,767 -20.49 54.03 -1,222,146 4,742,420
2016-09-15 2016-09-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 22,618 110,385 25.77 12.00 271,416 1,324,620
2016-08-30 2016-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 70,293 70,293
2016-08-30 2016-08-27 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2,207 2,207
2016-08-30 2016-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 29,000 87,767 49.35
2016-08-24 2016-08-23 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -3,831 0 -100.00
2016-08-24 2016-08-23 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -12,589 58,767 -17.64 48.00 -604,272 2,820,816
2016-08-24 2016-08-23 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 3,831 71,356 5.67 26.10 99,989 1,862,392
2016-08-24 2015-08-24 4/A SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise 245 0 -100.00
2016-08-22 2016-08-22 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -5,411 67,525 -7.42 46.59 -252,102 3,146,037
2016-08-22 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 44,946 44,946
2016-08-22 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2,554 2,554
2016-08-22 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 19,000 98,340 23.95
2016-08-22 2015-08-24 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -4,688 0 -100.00
2016-08-22 2015-08-24 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -245 0 -100.00
2016-08-22 2015-08-24 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 245 79,340 0.31 15.46 3,788 1,226,596
2016-08-22 2015-08-24 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 4,688 79,095 6.30 20.52 96,198 1,623,029
2016-08-22 2015-08-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -8,548 74,407 -10.30 42.02 -359,226 3,126,924
2016-05-26 2016-05-25 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy)
A - Award 34,000 34,000
2016-03-17 2016-03-17 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
P - Purchase 3,000 5,500 120.00 13.86 41,565 76,202
2016-02-10 2015-11-04 5 SGEN SEATTLE GENETICS INC /WA
Common Stock
G - Gift -8,223 90,117 -8.36
2016-01-05 2016-01-04 4 ATRA Atara Biotherapeutics, Inc.
Non-Qualified Stock Option (Right to Buy)
A - Award 10,500 10,500
2015-12-17 2015-12-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
P - Purchase 2,500 2,500 22.00 55,000 55,000
2015-11-06 2015-11-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -17,452 80,888 -17.75 42.50 -741,710 3,437,740
2015-08-25 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 44,946 44,946
2015-08-25 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2,554 2,554
2015-08-25 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 19,000 98,340 23.95
2015-08-25 2015-08-24 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -4,688 0 -100.00
2015-08-25 2015-08-24 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -245 0 -100.00
2015-08-25 2015-08-24 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 245 79,340 0.31 15.46 3,788 1,226,596
2015-08-25 2015-08-24 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 4,688 79,095 6.30 20.52 96,198 1,623,029
2015-08-25 2015-08-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -8,548 74,407 -10.30 42.02 -359,226 3,126,924
2015-06-25 2015-06-23 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy)
A - Award 24,000 24,000
2015-06-25 2015-06-23 4 STML STEMLINE THERAPEUTICS INC
Common Stock
A - Award 10,000 17,963 125.58
2015-05-08 2015-05-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -17,074 82,777 -17.10 40.38 -689,380 3,342,204
2015-03-30 2015-03-26 4 ATRA Atara Biotherapeutics, Inc.
Non-Qualified Stock Option (Right to Buy)
A - Award 25,000 25,000
2014-08-28 2014-08-27 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -8,333 0 -100.00
2014-08-28 2014-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 8,333 99,765 9.11 12.00 99,996 1,197,180
2014-08-27 2014-08-26 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 42,732 42,732
2014-08-27 2014-08-26 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2,268 2,268
2014-08-27 2014-08-26 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 18,000 91,432 24.51
2014-08-27 2014-08-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -4,818 73,432 -6.16 43.55 -209,819 3,197,890
2014-06-23 2014-06-19 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy)
A - Award 20,000 20,000
2014-01-23 2014-01-21 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -14,959 77,833 -16.12 48.02 -718,271 3,737,229
2014-01-23 2014-01-21 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -19,616 92,792 -17.45 47.90 -939,518 4,444,319
2014-01-23 2014-01-21 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -21,435 112,408 -16.02 47.87 -1,026,168 5,381,364
2013-09-11 2013-09-10 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -15,829 45,340 -25.88
2013-09-11 2013-09-10 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -20,312 12,500 -61.90
2013-09-11 2013-09-10 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -3,859 43,089 -8.22
2013-09-11 2013-09-10 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -2,000 133,843 -1.47 46.45 -92,900 6,217,021
2013-09-11 2013-09-10 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -15,829 135,843 -10.44 46.40 -734,489 6,303,319
2013-09-11 2013-09-10 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 15,829 151,672 11.65 26.10 413,137 3,958,639
2013-09-11 2013-09-10 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -3,859 135,843 -2.76 46.40 -179,063 6,303,319
2013-09-11 2013-09-10 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 3,859 139,702 2.84 15.46 59,660 2,159,793
2013-09-11 2013-09-10 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -20,312 135,843 -13.01 46.40 -942,507 6,303,319
2013-09-11 2013-09-10 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 20,312 156,155 14.95 20.52 416,802 3,204,301
2013-09-05 2013-09-05 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -15,000 46,948 -24.21
2013-09-05 2013-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -15,000 135,843 -9.94 44.00 -660,000 5,977,092
2013-09-05 2013-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 15,000 150,843 11.04 15.46 231,900 2,332,033
2013-09-05 2013-09-03 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -24,474 61,948 -28.32
2013-09-05 2013-09-03 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -6,333 0 -100.00
2013-09-05 2013-09-03 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -29,193 22,918 -56.02
2013-09-05 2013-09-03 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -8,223 0 -100.00
2013-09-05 2013-09-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -24,474 135,843 -15.27 42.29 -1,035,113 5,745,398
2013-09-05 2013-09-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 24,474 160,317 18.02 15.46 378,368 2,478,501
2013-09-05 2013-09-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -29,193 135,843 -17.69 42.29 -1,234,700 5,745,398
2013-09-05 2013-09-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 29,193 165,036 21.49 12.00 350,316 1,980,432
2013-09-05 2013-09-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -6,333 135,843 -4.45 42.29 -267,850 5,745,398
2013-09-05 2013-09-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 6,333 142,176 4.66 12.16 77,009 1,728,860
2013-09-05 2013-09-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 8,223 135,843 6.44 12.16 99,992 1,651,851
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 42,564 42,564 41.04 1,746,827 1,746,827
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2,436 2,436 41.04 99,973 99,973
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 18,000 127,620 16.42
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -3,328 109,620 -2.95 40.91 -136,148 4,484,554
2013-06-21 2013-06-19 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy)
A - Award 20,000 20,000
2013-03-12 2013-03-11 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -35,444 6,333 -84.84
2013-03-12 2013-03-11 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -14,556 52,111 -21.83
2013-03-12 2013-03-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -10,000 112,948 -8.13 31.15 -311,471 3,518,003
2013-03-12 2013-03-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -14,556 122,948 -10.59 31.16 -453,565 3,831,060
2013-03-12 2013-03-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 14,556 137,504 11.84 12.00 174,672 1,650,048
2013-03-12 2013-03-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -35,444 122,948 -22.38 31.16 -1,104,435 3,831,060
2013-03-12 2013-03-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 35,444 158,392 28.83 12.16 430,999 1,926,047
2013-03-06 2013-03-06 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -50,000 66,667 -42.86
2013-03-06 2013-03-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -50,000 122,948 -28.91 30.42 -1,520,955 3,739,968
2013-03-06 2013-03-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 50,000 172,948 40.67 12.00 600,000 2,075,376
2013-03-06 2013-03-05 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -12,567 41,777 -23.12
2013-03-06 2013-03-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -12,567 122,948 -9.27 28.95 -363,815 3,559,345
2013-03-06 2013-03-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 12,567 135,515 10.22 12.16 152,815 1,647,862
2013-03-06 2013-03-04 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -37,433 54,344 -40.79
2013-03-06 2013-03-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -37,433 122,948 -23.34 28.95 -1,083,685 3,559,345
2013-03-06 2013-03-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 37,433 160,381 30.45 12.16 455,185 1,950,233
2013-01-28 3 STML STEMLINE THERAPEUTICS INC
Common Stock
7,963
2013-01-04 2013-01-04 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -50,983 0 -100.00
2013-01-04 2013-01-04 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -9,017 0 -100.00
2013-01-04 2013-01-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -50,983 122,846 -29.33 24.95 -1,272,026 3,065,008
2013-01-04 2013-01-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 50,983 173,829 41.50 11.09 565,401 1,927,764
2013-01-04 2013-01-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 9,017 122,846 7.92 11.09 99,999 1,362,362
2012-12-19 2012-12-17 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -50,000 50,983 -49.51
2012-12-19 2012-12-17 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -4,554 0 -100.00
2012-12-19 2012-12-17 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -7,864 0 -100.00
2012-12-19 2012-12-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -50,000 113,829 -30.52 23.70 -1,184,955 2,697,645
2012-12-19 2012-12-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 50,000 163,829 43.93 11.09 554,500 1,816,864
2012-12-19 2012-12-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 4,554 113,829 4.17 10.29 46,861 1,171,300
2012-12-19 2012-12-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 7,864 109,275 7.75 10.20 80,213 1,114,605
2012-11-15 2012-11-13 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -24,811 0 -100.00
2012-11-15 2012-11-13 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -24,811 101,411 -19.66 23.59 -585,354 2,392,539
2012-11-15 2012-11-13 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 24,811 126,222 24.47 10.29 255,305 1,298,824
2012-11-15 2012-11-13 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -2,516 101,411 -2.42 23.60 -59,370 2,392,995
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -6,771 0 -100.00
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -4,539 0 -100.00
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -14,219 0 -100.00
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -3,649 0 -100.00
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -5,397 0 -100.00
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 5,397 103,927 5.48 4.45 24,017 462,475
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 14,219 98,530 16.86 5.63 80,053 554,724
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 3,649 84,311 4.52 5.07 18,500 427,457
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 4,539 80,662 5.96 6.74 30,593 543,662
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 6,771 76,123 9.76 10.33 69,944 786,351
2012-10-16 2012-10-15 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -25,000 24,811 -50.19
2012-10-16 2012-10-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -25,000 69,352 -26.50 25.01 -625,295 1,734,618
2012-10-16 2012-10-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 25,000 94,352 36.05 10.29 257,250 970,882
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 61,169 61,169 26.10 1,596,511 1,596,511
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 3,831 3,831 26.10 99,989 99,989
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 26,000 69,352 59.97
2012-08-15 2012-08-13 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -25,000 43,352 -36.58 24.01 -600,290 1,040,951
2012-06-20 2012-06-18 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -25,000 49,811 -33.42
2012-06-20 2012-06-18 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -25,000 68,073 -26.86 25.36 -634,000 1,726,331
2012-06-20 2012-06-18 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 25,000 93,073 36.73 10.29 257,250 957,721
2012-04-26 2012-04-25 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -10,635 74,811 -12.45
2012-04-26 2012-04-25 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -14,365 0 -100.00
2012-04-26 2012-04-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -10,635 68,073 -13.51 19.95 -212,168 1,358,056
2012-04-26 2012-04-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 10,635 78,708 15.62 10.29 109,434 809,905
2012-04-26 2012-04-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -14,365 68,073 -17.43 19.95 -286,582 1,358,056
2012-04-26 2012-04-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 14,365 82,438 21.10 10.20 146,523 840,868
2012-03-01 2012-02-28 4/A SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -4,000 68,073 -5.55 18.53 -74,114 1,261,291
2012-02-29 2012-02-28 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -18,229 0 -100.00
2012-02-29 2012-02-28 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -27,771 14,365 -65.91
2012-02-29 2012-02-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -27,771 72,073 -27.81 18.52 -514,330 1,334,821
2012-02-29 2012-02-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 27,771 99,844 38.53 10.20 283,264 1,018,409
2012-02-29 2012-02-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -18,229 72,073 -20.19 18.52 -337,608 1,334,821
2012-02-29 2012-02-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 18,229 90,302 25.29 10.33 188,306 932,820
2006-02-01 2006-01-31 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 38,281 38,281 5.63 215,522 215,522
2006-02-01 2006-01-31 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 14,219 14,219 5.63 80,053 80,053
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)